11.41 USD
▲+0.24+2.15%
盘后 11.39 -0.18%
2026-09-15
市值
$3.78B
市盈率
—
EPS
-0.55
股息率
—
52 周区间
2.75 – 12.58
成交量
3.73M
Beta
1.32
目标价
17.13
52W 低 2.7552W 高 12.58
价格走势
公司简介
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lil...